A phase 1B/phase 2A study of TRC105 (Endoglin Antibody) in combination with pazopanib (P) in patients (pts) with advanced soft tissue sarcoma (STS).

被引：15

作者：

Attia, Steven

Sankhala, Kamalesh Kumar

Riedel, Richard F.

Robinson, Steven Ian

Conry, Robert Martin

Boland, Patrick Mckay

Barve, Minal A.

Fritchie, Karen

Seon, Ben K.

Alvarez, Delia

Adams, Bonne J.

Shazer, Ronald L.

Theuer, Charles P.

Maki, Robert G.

机构：

[1] Mayo Clin, Jacksonville, FL 32224 USA

[2] Sarcoma Oncol Ctr, Santa Monica, CA USA

[3] Duke Univ, Med Ctr, Durham, NC USA

[4] Mayo Clin, Rochester, MN USA

[5] Kirkland Clin Acton Rd, Birmingham, AL USA

[6] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[7] Mary Crowley Canc Res Ctr, Dallas, TX 75221 USA

[8] TRACON Pharmaceut Inc, San Diego, CA USA

[9] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.11016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

11016

引用

页数：2